Develops generic pharmaceuticals for various diseases.
Jun 2026Revenue $141M/yrExpenses $106M/yr
Reached break-even Jul 2020
Figures by year
When did Elite Pharmaceuticals become profitable?
Its revenue passed its expenses in Jul 2020. In the 12 months to Jun 2026, revenue was $141M and expenses $106M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $149M | $99.8M | $49.1M |
| Mar 2025 | $84.0M | $64.4M | $19.6M |
| Mar 2024 | $56.6M | $45.8M | $10.8M |
| Mar 2023 | $34.2M | $30.5M | $3.68M |
| Mar 2022 | $32.3M | $27.2M | $5.07M |
| Mar 2021 | $25.4M | $23.3M | $2.10M |
| Mar 2020 | $18.0M | $20.3M | −$2.29M |
| Mar 2019 | $7.57M | $16.7M | −$9.16M |
| Mar 2018 | $7.46M | $16.5M | −$9.05M |
| Mar 2017 | $9.64M | $17.0M | −$7.36M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.